From bench to bedside: navigating bioanalytical method development and validation for clinical efficacy and regulatory compliance

Bioanalytical methods are indispensable in pharmaceutical development, serving as the backbone for ensuring clinical efficacy and regulatory compliance. The development and validation of these methods face numerous challenges for improved clarity and flow, as recommended. Biological matrices such as blood, plasma, urine, and tissues often contain endogenous substances that interfere with analyte detection, complicating efforts to achieve accuracy and reliability. These challenges highlight the need for innovative strategies to optimize bioanalytical methods for both clinical and regulatory success.